Sign In
Buy WTKWY
Wolters Kluwer N.V Earnings Calls
| Release date | Feb 25, 2026 |
| EPS estimate | $2.98 |
| EPS actual | $3.89 |
| EPS Surprise | 30.54% |
| Revenue estimate | 3.681B |
| Revenue actual | 3.583B |
| Revenue Surprise | -2.66% |
| Release date | Jul 30, 2025 |
| EPS estimate | $2.95 |
| EPS actual | $2.78 |
| EPS Surprise | -5.76% |
| Revenue estimate | 3.536B |
| Revenue actual | 3.594B |
| Revenue Surprise | 1.62% |
| Release date | Jul 29, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Release date | Feb 26, 2025 |
| EPS estimate | $2.64 |
| EPS actual | $2.48 |
| EPS Surprise | -6.06% |
| Revenue estimate | 3.175B |
| Revenue actual | 3.132B |
| Revenue Surprise | -1.34% |
Last 4 Quarters for Wolters Kluwer N.V
Below you can see how WTKWY performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 26, 2025 |
| Price on release | $161.42 |
| EPS estimate | $2.64 |
| EPS actual | $2.48 |
| EPS surprise | -6.06% |
| Date | Price |
|---|---|
| Feb 20, 2025 | $184.04 |
| Feb 21, 2025 | $180.72 |
| Feb 24, 2025 | $179.83 |
| Feb 25, 2025 | $181.50 |
| Feb 26, 2025 | $161.42 |
| Feb 27, 2025 | $155.11 |
| Feb 28, 2025 | $153.00 |
| Mar 03, 2025 | $157.42 |
| Mar 04, 2025 | $153.60 |
| 4 days before | -12.29% |
| 4 days after | -4.84% |
| On release day | -3.48% |
| Change in period | -16.54% |
| Release date | Jul 29, 2025 |
| Price on release | $156.30 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Jul 23, 2025 | $163.60 |
| Jul 24, 2025 | $160.76 |
| Jul 25, 2025 | $158.37 |
| Jul 28, 2025 | $156.28 |
| Jul 29, 2025 | $156.30 |
| Jul 30, 2025 | $156.57 |
| Jul 31, 2025 | $155.51 |
| Aug 01, 2025 | $154.00 |
| Aug 04, 2025 | $154.98 |
| 4 days before | -4.46% |
| 4 days after | -0.84% |
| On release day | 0.173% |
| Change in period | -5.27% |
| Release date | Jul 30, 2025 |
| Price on release | $156.57 |
| EPS estimate | $2.95 |
| EPS actual | $2.78 |
| EPS surprise | -5.76% |
| Date | Price |
|---|---|
| Jul 24, 2025 | $160.76 |
| Jul 25, 2025 | $158.37 |
| Jul 28, 2025 | $156.28 |
| Jul 29, 2025 | $156.30 |
| Jul 30, 2025 | $156.57 |
| Jul 31, 2025 | $155.51 |
| Aug 01, 2025 | $154.00 |
| Aug 04, 2025 | $154.98 |
| Aug 05, 2025 | $152.59 |
| 4 days before | -2.61% |
| 4 days after | -2.54% |
| On release day | -0.677% |
| Change in period | -5.08% |
| Release date | Feb 25, 2026 |
| Price on release | $75.16 |
| EPS estimate | $2.98 |
| EPS actual | $3.89 |
| EPS surprise | 30.54% |
| Date | Price |
|---|---|
| Feb 19, 2026 | $73.35 |
| Feb 20, 2026 | $73.31 |
| Feb 23, 2026 | $70.65 |
| Feb 24, 2026 | $73.61 |
| Feb 25, 2026 | $75.16 |
| Feb 26, 2026 | $77.86 |
| Feb 27, 2026 | $81.00 |
| Mar 02, 2026 | $79.21 |
| Mar 03, 2026 | $79.63 |
| 4 days before | 2.47% |
| 4 days after | 5.95% |
| On release day | 3.59% |
| Change in period | 8.56% |
Wolters Kluwer N.V Earnings Call Transcript Summary of Q4 2025
Wolters Kluwer delivered a solid FY 2025 with EUR 6.125bn revenues (6% organic growth), adjusted operating profit of EUR 1.687bn (+9% cc) and an adjusted operating margin of 27.5% (up 40bps). Recurring revenues (83% of total) grew 7% organically and adjusted free cash flow rose ~10% to EUR 1.348bn. Key divisional performance: Health +5% organic (Clinical Solutions +7%), Tax & Accounting +7% (strong cloud growth and AI-enabled modules), Financial & Corporate Compliance +3% (transactional slowdown), Legal & Regulatory +5%, Corporate Performance & ESG +7% (cloud momentum). Print is <5% of revenue and continues to decline. Management highlighted meaningful progress embedding generative/agentic AI across products (UpToDate Expert AI, CCH Axcess Expert AI), with ~70% of digital revenue now AI-powered and strong customer uptake (c.30% of UpToDate enterprise accounts already signed for Expert AI, with expansion expected). Capital allocation: acquisitions (~EUR 896m in 2025), divestment proceeds (~EUR 400m), dividends up 8% to EUR 2.52 per share proposed, and a EUR 500m buyback program for 2026 (EUR 100m already executed). Net debt/EBITDA sits at c.2.0x; ROIC ~18%. Outlook for 2026: continued good organic growth, further margin expansion, and high-single-digit diluted adjusted EPS growth (cc), while increasing product development investment to 12–13% of revenues to accelerate AI roadmap. Management emphasized leveraging proprietary content, validated AI with expert-in-the-loop processes, platform integration and ecosystem partnerships as competitive moats.
